SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa
Topics & Concepts
MedicineIntravenous ImmunoglobulinsAntibodyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Immunology2019-20 coronavirus outbreakImmunoglobulin GVirologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseCOVID-19 Clinical Research StudiesDermatological and COVID-19 studiesSARS-CoV-2 and COVID-19 Research